HLA-DRB1

protein-coding

major histocompatibility complex, class II, DR beta 1, the group of C1-set domain containing|Histocompatibility complex

Gene summary

HLA-DRB1 belongs to the HLA class II beta chain paralogs. The class II molecule is a heterodimer consisting of an alpha (DRA) and a beta chain (DRB), both anchored in the membrane. It plays a central role in the immune system by presenting peptides derived from extracellular proteins. Class II molecules are expressed in antigen presenting cells. The beta chain is approximately 26-28 kDa. It is encoded by 6 exons. Exon one encodes the leader peptide; exons 2 and 3 encode the two extracellular domains; exon 4 encodes the transmembrane domain; and exon 5 encodes the cytoplasmic tail. Within the DR molecule the beta chain contains all the polymorphisms specifying the peptide binding specificities. Hundreds of DRB1 alleles have been described and some alleles have increased frequencies associated with certain diseases or conditions. For example, DRB1*1302 has been related to acute and chronic hepatitis B virus persistence. There are multiple pseudogenes of this gene. [provided by RefSeq, Jul 2020]

Previous symbols:
  • HLA-DR1B

MANE transcript

NM_002124.4

Inheritance

—

ClinVar variants

P:3U:34B:26

Top phenotype

systemic lupus erythematosus

gnomAD constraint

pLI —, LoF o/e 0.59

Max pathogenic AF

—

Genomic locus

chr6:32,577,902-32,589,848

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~11.9 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

systemic lupus erythematosusSUPPORTIVE

Inheritance Pattern: Unknown

Disease ID:MONDO:0007915

Submitter: Orphanet

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to HLA-DRB1 variants in ClinVar

5 Conditions Cataloged
not providedTotal: 24
not specifiedTotal: 11
Multiple sclerosis, susceptibility toTotal: 4
Pulmonary artery atresiaTotal: 1
Peritoneal GliomatosisTotal: 1

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_002124.4. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
11
clinvar
11
missense
1
clinvar
21
clinvar
9
clinvar
31
nonsense
2
clinvar
1
clinvar
3
start loss
0
frameshift
1
clinvar
3
clinvar
1
clinvar
3
clinvar
8
splice donor/acceptor (+/-2bp)
1
clinvar
8
clinvar
1
clinvar
10
Total213423363

Highest pathogenic variant AF is 0.000018686898

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 26 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_002124.4RefSeqNP_002115.26MANE Select
ENST00000360004.6EnsemblENSP00000353099.56MANE Select
ENST00000696610.1EnsemblENSP00000512754.12Standard
ENST00000859897.1EnsemblENSP00000529956.13Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Antigen processing and presentation - Homo sapiens (human)
  • Cell adhesion molecules (CAMs) - Homo sapiens (human)
  • Type I diabetes mellitus - Homo sapiens (human)
  • Allograft rejection - Homo sapiens (human)
  • Graft-versus-host disease - Homo sapiens (human)

Biological Process

  • polysaccharide assembly with MHC class II protein complex
  • antigen processing and presentation of exogenous peptide antigen via MHC class II
  • T cell receptor signaling pathway
  • interferon-gamma-mediated signaling pathway

Molecular Function

  • MHC class II protein complex binding
  • peptide antigen binding

Cellular Component

  • Golgi membrane
  • lysosomal membrane
  • plasma membrane
  • cell surface
  • ER to Golgi transport vesicle membrane

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000360004
Coding exons
6
Length
11080
Individuals with no LoFs
125037
Homozygous LoFs
0
Heterozygous LoFs
1
Defined
125038
p
0.00000400
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense1.18841200.6980.000005701549
Missense (PolyPhen)1842.2820.42571569
Synonymous1.063948.40.8050.00000233472
Loss of Function1.23610.20.5864.63e-7127

Population LoF Frequency

PopulationCAFp-valueStatus
African00.0absent
Latino/Admixed American00.0absent
Ashkenazi Jewish00.0absent
East Asian00.0absent
Finnish0.0000460.000046rare
European (Non-Finnish)00.0absent
South Asian00.0absent
Other00.0absent

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Binds peptides derived from antigens that access the endocytic route of antigen presenting cells (APC) and presents them on the cell surface for recognition by the CD4 T-cells. The peptide binding cleft accommodates peptides of 10-30 residues. The peptides presented by MHC class II molecules are generated mostly by degradation of proteins that access the endocytic route; where they are processed by lysosomal proteases and other hydrolases. Exogenous antigens that have been endocytosed by the APC are thus readily available for presentation via MHC II molecules; and for this reason this antigen presentation pathway is usually referred to as exogenous. As membrane proteins on their way to degradation in lysosomes as part of their normal turn-over are also contained in the endosomal/lysosomal compartments; exogenous antigens must compete with those derived from endogenous components. Autophagy is also a source of endogenous peptides; autophagosomes constitutively fuse with MHC class II loading compartments. In addition to APCs; other cells of the gastrointestinal tract; such as epithelial cells; express MHC class II molecules and CD74 and act as APCs; which is an unusual trait of the GI tract. To produce a MHC class II molecule that presents an antigen; three MHC class II molecules (heterodimers of an alpha and a beta chain) associate with a CD74 trimer in the ER to form a heterononamer. Soon after the entry of this complex into the endosomal/lysosomal system where antigen processing occurs; CD74 undergoes a sequential degradation by various proteases; including CTSS and CTSL; leaving a small fragment termed CLIP (class-II-associated invariant chain peptide). The removal of CLIP is facilitated by HLA-DM via direct binding to the alpha-beta-CLIP complex so that CLIP is released. HLA-DM stabilizes MHC class II molecules until primary high affinity antigenic peptides are bound. The MHC II molecule bound to a peptide is then transported to the cell membrane surface. In B-cells; the interaction between HLA-DM and MHC class II molecules is regulated by HLA-DO. Primary dendritic cells (DCs) also to express HLA-DO. Lysosomal microenvironment has been implicated in the regulation of antigen loading into MHC II molecules; increased acidification produces increased proteolysis and efficient peptide loading.;

Intolerance Scores

LoFtool
1.00
RVIS EVS
2.97
RVIS percentile EVS
99.19

Essentials

Essential (CRISPR)
N
Essential (gene trap)
N
Indispensability pred.
E
Indispensability score
0.786

Gene Damage Prediction

AllRecessiveDominant
MendelianHighHighHigh
Primary ImmunodeficiencyHighHighHigh
CancerHighHighHigh
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.